Roflumilast cream 0.15% was well tolerated and significantly improved symptoms in adults and children with mild to moderate atopicdermatitis (AD) in two phase 3 trials. The two phase 3 randomized ...
ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentationAdditionally, two posters on data from the pioneering use of tape stripping for biomarker ...
Results that may be inaccessible to you are currently showing.